November 16, 2026 at 12:38 PM UTC
Medicus Pharma Ltd. reports material agreement in SEC 8-K
Medicus Pharma Ltd. filed an 8-K covering a material definitive agreement, an unregistered sale of equity securities, SEC Item 3.03, and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 16, 2026 at 12:30 PM UTC
Open official source